🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mohamed Samai

University of Sierra Leone

ORCID: 0000-0002-1427-9482

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial”.

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00125-0

N/A

1.7DataRank · unranked

95 citations

Daniela Manno, Muhammed O. Afolabi, Babajide Keshinro, Viki Bockstal, Baimba Rogers +87 more

Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola

Emerging infectious diseases(2020)10.3201/eid2603.191018

N/A

1.6DataRank · unranked

33 citations

Rosalind J. Carter, Susan T. Goldstein, Olamide D. Jarrett, Elena Szefer, Augustin E Fombah +4 more

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults

Clinical Infectious Diseases(2023)10.1093/cid/ciad693

N/A

0.671DataRank · unranked

16 citations

Ken Liu, Édouard Lhomme, Julie Blie, John McCullough, Matthew Onorato +90 more

Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols

PLoS ONE(2022)10.1371/journal.pone.0270968

N/A

0DataRank · unranked

11 citations

Suzanne Fleck, Bailah Leigh, Philip Ayieko, Daniel Tindanbil, Tuda Otieno +12 more

Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory

EBioMedicine(2023)10.1016/j.ebiom.2023.104562

N/A

0DataRank · unranked

10 citations

Houreratou Barry, Mark Kieh, Zacchaeus Anywaine, Baimba Rogers, Seydou Doumbia +22 more

A study protocol for the assessment of antibiotic use and bacterial antimicrobial resistance among children under five years of age: implications for a resource-limited setting

medRxiv(2025)10.1101/2025.08.03.25332900

N/A

0DataRank · unranked

0 citations

Troy D. Moon, John S. Schieffelin, Cynthia Ayefoumi Adinortey, Gustavo Amorim, Isatta Wurie +4 more

SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey

BMJ Global Health(2021)10.1136/bmjgh-2021-007271

N/A

0DataRank · unranked

59 citations

Sulaiman Lakoh, J. Daniel Kelly, Joseph Sam Kanu, James Sylvester Squire, Zikan Koroma +19 more

Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab243

N/A

0DataRank · unranked

18 citations

Jakub K. Simon, Marc‐Alain Widdowson, Mohamed Samai, Eric Rogier, Jennifer Legardy-Williams +9 more